Futura Medical (LON:FUM) Stock Price Down 11.5% – Here’s Why

Futura Medical plc (LON:FUM) shares traded down 11.5% during trading on Wednesday . The company traded as low as GBX 0.45 and last traded at GBX 0.46. 2,226,471 shares were traded during trading, a decline of 74% from the average session volume of 8,569,635 shares. The stock had previously closed at GBX 0.52.

Futura Medical Price Performance

The firm has a market cap of £3.17 million, a P/E ratio of -0.20 and a beta of 0.02. The company’s 50 day moving average is GBX 0.72 and its two-hundred day moving average is GBX 1.05.

Futura Medical (LON:FUM) last issued its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share (EPS) for the quarter. The firm had revenue of GBX 170 million for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. Research analysts predict that Futura Medical plc will post 2.8486672 EPS for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.